Combination Therapy for the Treatment of Arterial Hypertension

被引:0
作者
Watschinger, B. [1 ]
机构
[1] Med Univ Wien, Univ Klin Innere Med 3, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
来源
JOURNAL FUR HYPERTONIE | 2010年 / 14卷 / 03期
关键词
Arterial hypertension; blood pressure control; combination therapy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An increasing number of drugs are available for the treatment of arterial hypertension, providing the option for an even greater number of possible combinations in order to reach the treatment targets for blood pressure. As hypertension is still not well-controlled in the population, combination therapies are now the focus of therapeutic considerations. Recent evidence from controlled studies suggests that combination therapies are superior to monotherapies in preventing cardiovascular events and mortality.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 43 条
  • [1] Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial
    Bakris, GL
    Fonseca, V
    Katholi, RE
    McGill, JB
    Messerli, FH
    Phillips, RA
    Raskin, P
    Wright, JT
    Oakes, R
    Lukas, MA
    Anderson, KM
    Bell, DSH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18): : 2227 - 2236
  • [2] The importance of blood pressure control in the patient with diabetes
    Bakris, GL
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 116 : 30 - 38
  • [3] Triple Fixed-Dose Combination Therapy Back to the Past
    Black, Henry R.
    [J]. HYPERTENSION, 2009, 54 (01) : 19 - 22
  • [4] Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide A Randomized Clinical Trial
    Calhoun, David A.
    Lacourciere, Yves
    Chiang, Yann Tong
    Glazer, Robert D.
    [J]. HYPERTENSION, 2009, 54 (01) : 32 - 39
  • [5] CHOBANIAN AV, 2003, HYPERTENSION, V42, P1206, DOI DOI 10.1161/01.HYP.0000107251.49515.c2
  • [6] Crawford MH, 2009, AM J CARDIOVASC DRUG, V9, P1, DOI 10.2165/00129784-200909010-00001
  • [7] Cushman William C, 2002, J Clin Hypertens (Greenwich), V4, P393
  • [8] Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
    Dahlöf, B
    Sever, PS
    Poulter, NR
    Wedel, H
    Beevers, DG
    Caulfield, M
    Collins, R
    Kjeldsen, SE
    Kristinsson, A
    McInnes, GT
    Mehlsen, J
    Nieminen, M
    O'Brien, E
    Östergren, J
    [J]. LANCET, 2005, 366 (9489) : 895 - 906
  • [9] Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension
    Doulton, TWR
    He, FJ
    MacGregor, GA
    [J]. HYPERTENSION, 2005, 45 (05) : 880 - 886
  • [10] Incident diabetes in clinical trials of anti hypertensive drugs: a network meta-analysis
    Elliott, William J.
    Meyer, Peter M.
    [J]. LANCET, 2007, 369 (9557) : 201 - 207